Skip to content
TriangleGet started
← Survival collections

ARCHIVED POPULATION DATA

Prostate

Archived November 2024 SEER release. This is relative survival from diagnosis for the published population, not an individual prediction or a treatment-effect estimate.

Relative survival across follow-up

0%25%50%75%100%0246810Years since diagnosis
Exact archived source values · CI = confidence interval
YearRelative survival (%)95% CI lower95% CI upperStandard errorCases
0100Not publishedNot publishedNot published1667649
199.267399.237999.29560.01471667649
298.755298.713698.79540.02091667649
398.411698.3698.46160.02591667649
498.21898.157498.27670.03051667649
598.099598.029998.16660.03491667649
698.02597.946498.10060.03931667649
797.955797.867898.04010.0441667649
897.922397.824598.01570.04881667649
997.913297.804998.01610.05391667649
1097.89597.775498.00820.05941667649
Permanent reference to this archived population →
Source definitions, footnotes and provenance
age and race caveat
Published age/race categories can overlap. They are selectable strata, not partitions to add together.
cohort count definition
Source Number of Cases, repeated by follow-up row; not people remaining at risk.
content sha256
a8a4bbda0da68b70cdfcaf9380f42f739a87280118e5fc3a013d8254cf43654c
dimensions
Age at Diagnosis
  1. Ages 15-39
  2. Ages 40-64
  3. Ages 50-64
  4. Ages 65+
  5. Ages 65-74
  6. Ages 75+
  7. Ages < 15
  8. Ages < 20
  9. Ages < 50
  10. All Ages
Race/Ethnicity
  1. All Races / Ethnicities
  2. Black (includes Hispanic)
  3. Hispanic (any race)
  4. Non-Hispanic American Indian / Alaska Native
  5. Non-Hispanic Asian / Pacific Islander
  6. Non-Hispanic Black
  7. Non-Hispanic White
  8. White (includes Hispanic)
Sex
  1. Male
Stage at Diagnosis
  1. All Stages
  2. Distant
  3. Localized
  4. Regional
  5. Unstaged
Years of Diagnosis
  1. 2000-2021
id
prostate
immutable id
seer-group:prostate@a8a4bbda0da68b70cdfcaf9380f42f739a87280118e5fc3a013d8254cf43654c
method
Relative survival calculated using monthly intervals; table publishes annual landmarks from diagnosis through year ten.
missing value definition
Source dash (-) does not differentiate suppression, unavailable data, or other missingness. No suppression reason is inferred.
normalized source
file
normalized/followup/prostate.json.gz
sha256
79f55b568dbd57d3a534b7f39cff9be39275aaed70fc3574ad3e2ccb49eea3d6
period interpretation
The displayed diagnosis period is the source table label. Exact case-eligible years are not inferred from it.
registry
SEER 21 (excluding Illinois)
sheet
Prostate
site
Prostate
source
bytes
45275886
file
raw/Survival by Survival Time, November 2024.xlsx
retrieved at
2026-09-09T23:23:39.141323+00:00
sha256
4300662c48518fc384f68c039c8bbcd2a072e603576b36d327e6b17f80771e34
title
Survival by Survival Time
source footnotes
  1. row
    4408
    values
    1. Footnotes
  2. row
    4409
    values
    1. Data Source:
  3. row
    4410
    values
    1. -SEER Incidence Data, November 2024 Submission (1975-2022), SEER 21 registries [https://seer.cancer.gov/registries/terms.html] (excluding Illinois).
  4. row
    4411
    values
    1. -Expected Survival Life Tables [https://seer.cancer.gov/expsurvival/] by Socio-Economic Standards.
  5. row
    4412
    values
    1. Methodology:
  6. row
    4413
    values
    1. -The relative survival rates are calculated using monthly intervals.
  7. row
    4414
    values
    1. Race/Ethnicity Coding:
  8. row
    4415
    values
    1. -For more details on SEER race/ethnicity groupings, please see Race and Hispanic Ethnicity Changes [https://seer.cancer.gov/seerstat/variables/seer/race_ethnicity/].
  9. row
    4416
    values
    1. -Incidence data for Hispanics and Non-Hispanics are based on the NAACCR Hispanic Latino Identification Algorithm (NHIA).
  10. row
    4417
    values
    1. -Rates for American Indians/Alaska Natives only include cases that are in a Purchased/Referred Care Delivery Area (PRCDA).
  11. row
    4418
    values
    1. Cancer Site Coding:
  12. row
    4419
    values
    1. -See SEER*Explorer Cancer Site Definitions [https://seer.cancer.gov/statistics-network/explorer/cancer-sites.html] for details about the cancer site coding used for SEER Incidence data.
source header rows
    1. SEER Explorer Data Archive, November 2024 SEER Submission (April 2025 Release)
    1. Prostate
    1. SEER Relative Survival Rates by Time Since Diagnosis
    source missing marker
    -
    stage coding footnotes
    1. row
      4420
      values
      1. -Stage at diagnosis is calculated using the Combined Summary Stage (2004+) recode, created from SEER Combined Summary Stage 2000 (2004-2017) & Derived Summary Stage 2018 (2018+). For more information, see the SEER documentation[https://seer.cancer.gov/seerstat/variables/seer/lrd-stage].
    stage period caveat
    Combined Summary Stage (2004+) uses coding starting in 2004; the 2000-2021 label must not be read as full stage-specific coverage from 2000.
    stage system
    Combined Summary Stage (2004+)

    Preserved source evidence · Independent clinical review pending · Not medical advice